Management of patients with type 2 diabetes and MASLD: An overview and joint statement

Chouik, Y; Canivet, CM; Julla, JB; Mouillot, T; Parlati, L; Rouland, A; Smati, S; Tramunt, B; Anty, R; Boursier, J; Carette, C; Cariou, B; Castera, L; Garioud, A; Guerci, B; Gourdy, P; Guillaume, M; Lassailly, G; Pais, R; Petit, JM; Serfaty, L; Vergès, B; Caussy, C; AFEF and SFD

doi:10.1016/j.diabet.2025.101709

Type 2 & other diabetes

Management of patients with type 2 diabetes and MASLD: An overview and joint statement

Diabetes MetabPublished 15 Oct 2025Joint statement

Read the original article ↗PubMed

Cite

Recommendations

As issued by the authors

Systematic screening for advanced fibrosis related to MASLD is recommended for patients with T2D
Adapt drug therapy in the presence of significant fibrosis to slow liver disease progression and reduce the risk of associated clinical events

Reference

Issued by: French Association for the Study of the Liver (AFEF) and Francophone Diabetes Society (SFD)
Document: Overview and joint statement (expert group)
Scope: MASLD screening and therapeutic management in patients with T2D: dietary and behavioral management, pharmacological treatment of T2D, bariatric procedures; guidance for diabetologists and primary care physicians

Authors: Chouik Y, Canivet CM, Julla JB, Mouillot T, Parlati L, Rouland A, et al.
All 24 authors
Chouik Y, Canivet CM, Julla JB, Mouillot T, Parlati L, Rouland A, Smati S, Tramunt B, Anty R, Boursier J, Carette C, Cariou B, Castera L, Garioud A, Guerci B, Gourdy P, Guillaume M, Lassailly G, Pais R, Petit JM, Serfaty L, Vergès B, Caussy C, AFEF and SFD
Journal: Diabetes & Metabolism
Published: 15 Oct 2025
DOI: 10.1016/j.diabet.2025.101709
PubMed: 41106720

Topic: Type 2 & other diabetes
Also indexed: Lipids & metabolic liver disease

Original publication

Management of patients with type 2 diabetes and MASLD: An overview and joint statement. Diabetes Metab. Published 15 October 2025. doi:10.1016/j.diabet.2025.101709

Read the original article ↗

Composed by AI from the published abstract and checked against it. How Briefs are made →